Works matching AU Kornmann, Marko


Results: 61
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Brain Metastasis in Pancreatic Cancer.

    Published in:
    International Journal of Molecular Sciences, 2013, v. 14, n. 2, p. 4163, doi. 10.3390/ijms14024163
    By:
    • Lemke, Johannes;
    • Scheele, Jan;
    • Kapapa, Thomas;
    • Wirtz, Christian Rainer;
    • Henne-Bruns, Doris;
    • Kornmann, Marko
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.

    Published in:
    2018
    By:
    • Ettrich, Thomas J.;
    • Berger, Andreas W.;
    • Perkhofer, Lukas;
    • Daum, Severin;
    • König, Alexander;
    • Dickhut, Andreas;
    • Wittel, Uwe;
    • Wille, Kai;
    • Geissler, Michael;
    • Algül, Hana;
    • Gallmeier, Eike;
    • Atzpodien, Jens;
    • Kornmann, Marko;
    • Muche, Rainer;
    • Prasnikar, Nicole;
    • Tannapfel, Andrea;
    • Reinacher-Schick, Anke;
    • Uhl, Waldemar;
    • Seufferlein, Thomas
    Publication type:
    journal article
    28
    29

    Dermoid cyst of the pancreas.

    Published in:
    2010
    By:
    • Scheele, Jan;
    • Barth, Thomas F. E.;
    • Straßburg, Juliane;
    • Juchems, Markus;
    • Kornmann, Marko;
    • Henne-Bruns, Doris
    Publication type:
    Letter
    30
    31
    32
    33

    Multimorbidität in der Leberchirurgie.

    Published in:
    Chirurgie (2731-6971), 2025, v. 96, n. 2, p. 102, doi. 10.1007/s00104-024-02222-7
    By:
    • Birgin, Emrullah;
    • Heil, Jan;
    • Miller, Elisabeth;
    • Kornmann, Marko;
    • Rahbari, Nuh N.
    Publication type:
    Article
    34
    35

    Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.

    Published in:
    International Journal of Cancer, 2015, v. 136, n. 12, p. 2799, doi. 10.1002/ijc.29346
    By:
    • Richter, Julia;
    • Ullah, Kalim;
    • Xu, Pengfei;
    • Alscher, Vanessa;
    • Blatz, Annette;
    • Peifer, Christian;
    • Halekotte, Jakob;
    • Leban, Johann;
    • Vitt, Daniel;
    • Holzmann, Karlheinz;
    • Bakulev, Vasiliy;
    • Pinna, Lorenzo A.;
    • Henne‐Bruns, Doris;
    • Hillenbrand, Andreas;
    • Kornmann, Marko;
    • Leithäuser, Frank;
    • Bischof, Joachim;
    • Knippschild, Uwe
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42

    A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response.

    Published in:
    Cancers, 2021, v. 13, n. 11, p. 2539, doi. 10.3390/cancers13112539
    By:
    • Beutel, Alica K.;
    • Schütte, Lena;
    • Scheible, Jeanette;
    • Roger, Elodie;
    • Müller, Martin;
    • Perkhofer, Lukas;
    • Kestler, Annika M. T. U.;
    • Kraus, Johann M.;
    • Kestler, Hans A.;
    • Barth, Thomas F. E.;
    • Lemke, Johannes;
    • Kornmann, Marko;
    • Ettrich, Thomas J.;
    • Gout, Johann;
    • Seufferlein, Thomas;
    • Kleger, Alexander
    Publication type:
    Article
    43

    Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2014, v. 33, n. 1, p. 1, doi. 10.1186/s13046-014-0083-8
    By:
    • Thomaidis, Thomas;
    • Maderer, Annett;
    • Formentini, Andrea;
    • Bauer, Susanne;
    • Trautmann, Mario;
    • Schwarz, Michael;
    • Neumann, Wiebke;
    • Kittner, Jens Martin;
    • Schad, Arno;
    • Link, Karl-Heinrich;
    • Rey, Johannes Wilhelm;
    • Weinmann, Arndt;
    • Hoffman, Arthur;
    • Galle, Peter Robert;
    • Kornmann, Marko;
    • Moehler, Markus
    Publication type:
    Article
    44

    Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy.

    Published in:
    Cancer (0008543X), 2000, v. 89, n. 2, p. 288, doi. 10.1002/1097-0142(20000715)89:2<288::AID-CNCR13>3.0.CO;2-O
    By:
    • Link, Karl H.;
    • Kornmann, Marko;
    • Butzer, Urwe;
    • Leder, Gerd;
    • Sunelaitis, Ellen;
    • Pillasch, Jürgen;
    • Salonga, Dennis;
    • Danenberg, Kathleen D.;
    • Danenberg, Peter V.;
    • Beger, Hans G.
    Publication type:
    Article
    45
    46
    47
    48
    49
    50